Chromoblastomycosis is a chronic subcutaneous fungal infection caused by pigmented fungi belonging to the dematiaceous group, most commonly Fonsecaeapedrosoi, Cladophialophoracarrionii, and Phialophora verrucosa [1]. The infection usually occurs following traumatic implantation of fungal elements into the skin, particularly in individuals engaged in agricultural or outdoor occupations [2].
The disease is predominantly reported in tropical and subtropical regions such as Latin America, Africa, and Asia [3]. The lower limbs are the most commonly affected sites due to their greater exposure to trauma and contaminated soil or plant material [4].
Clinically, chromoblastomycosis is characterized by slowly progressive lesions that may initially appear as papules or nodules and later evolve into verrucous plaques or tumorous masses [5]. Long-standing lesions may lead to fibrosis, scarring, and obstruction of lymphatic drainage resulting in secondary lymphedema [6].The hallmark diagnostic feature is the presence of sclerotic bodies (Medlar bodies) observed on direct microscopy or histopathological examination [7]. These thick-walled pigmented fungal structures are considered pathognomonic for chromoblastomycosis.The treatment of chromoblastomycosis can be challenging due to the chronic nature of the infection and the potential for recurrence. Systemic antifungal therapy with Itraconazole and Terbinafine remains the mainstay of treatment [8].
We report a case of extensive chromoblastomycosis presenting with verrucous white plaques and elephantiasis-like swelling of the lower limb.
CASE PRESENTATION
A middle-aged male patient presented to the dermatology outpatient department with complaints of gradually progressive warty lesions over the right lower limb for several years. The lesions reportedly began as a small papule following minor trauma sustained during outdoor work. Over time, the lesion increased in size and developed into multiple verrucous plaques.
The patient also reported progressive swelling of the affected leg associated with mild discomfort. There was no history of fever, systemic symptoms, or similar lesions elsewhere on the body.
On dermatological examination, the right lower limb showed multiple extensive hyperkeratotic white verrucousadherant plaques involving the anterior aspect of the leg. The lesions had irregular margins and a characteristic cauliflower-like surface as shown in figure 1 (a). Surrounding skin showed erythema and induration.Diffuse swelling of the affected limb was present extending from the ankle to the lower third of the leg suggestive of chronic lymphedema. The contralateral limb showed healed lesions with post-inflammatory pigmentation. On close-up view of the verrucous lesion over the right leg demonstrating irregular hyperkeratotic plaques with thick crusting and papillomatous surface consistent with advanced Chromoblastomycosis, as shown in figure 1(b).
Follow-up clinical image as given in figure 2(a) and 2(b) showed partial resolution of the verrucous plaques with residual erythema, scaling, and post-inflammatory changes after initiation of 2 weeks duration of antifungal therapy with Itraconazole 100 mg twice daily .
Routine hematological and biochemical investigations were within normal limits. Direct microscopic examination of skin scrapings using potassium hydroxide preparation demonstrated thick-walled brown pigmented fungal structures consistent with Medlar bodies, supporting the diagnosis of chromoblastomycosis [7].
A skin biopsy was performed from the verrucous plaque. Histopathological examination revealed marked pseudoepitheliomatous hyperplasia of the epidermis with granulomatous inflammatory infiltrate composed of lymphocytes, histiocytes, and multinucleated giant cells. Numerous brown pigmented fungal bodies were observed within the dermis.These findings confirmed the diagnosis of chromoblastomycosis.
The patient was started on systemic antifungal therapy with Itraconazole 100 mg twice daily, along with supportive measures including limb elevation and local wound care.
Chromoblastomycosis is a chronic fungal infection characterized by slow progression and significant morbidity if left untreated [1]. The disease most frequently affects adult males involved in agricultural work due to repeated exposure to contaminated soil and plant material [2].The infection is initiated following traumatic implantation of fungal spores into the skin. The host immune response leads to chronic granulomatous inflammation resulting in progressive skin lesions [3].The clinical spectrum of chromoblastomycosis includes several morphological types such as Nodular form, Verrucous form, Plaque form, Tumoral form and Cicatricial form. Among these, the verrucous type is the most common and is characterized by cauliflower-like growths with hyperkeratosis [5].
One of the notable complications of long-standing chromoblastomycosis is chronic lymphedema. Persistent inflammation and fibrosis may obstruct lymphatic channels leading to swelling of the affected limb and elephantiasis-like changes [6].The differential diagnosis of chronic verrucous lesions of the lower limb includesElephantiasisNostrasVerrucosa, Cutaneous Tuberculosis, Mycetoma and Verrucous Carcinoma.Laboratory confirmation relies on demonstration of characteristic Medlar bodies on microscopy and histopathology [7]. Fungal culture may further identify the species involved [9].Treatment of chromoblastomycosis usually requires prolonged antifungal therapy. Systemic agents such as Itraconazole and Terbinafine have shown favorable outcomes [8,10].Adjunctive treatment modalities including cryotherapy, thermotherapy, and surgical excision may be beneficial in localized lesions [11].Early diagnosis and treatment are essential to prevent complications such as scarring, deformity, and chronic lymphedema [12].
Chromoblastomycosis remains an important cause of chronic fungal infection in tropical and subtropical regions. Delayed diagnosis may result in extensive lesions and complications such as secondary lymphedema.This case highlights the need for early recognition of chromoblastomycosis in patients presenting with chronic verrucous plaques of the lower limb. Prompt diagnosis and appropriate antifungal therapy are essential for successful management and prevention of disability.
Disclaimer: The authors affirm that there are no conflicts of interest associated with the publication of this paper.
This paper did not receive any external funding. The co-authors independently financed the data collection and the preparation of this manuscript.
[1] Queiroz-Telles F, de Hoog GS, Santos DWCL, Salgado CG, Vicente VA, Bonifaz A, et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2017;55(6):531–546.
[2] Ameen M. Managing chromoblastomycosis. Clin Exp Dermatol. 2009;34(8):849–854.
[3] World Health Organization. Chromoblastomycosis and other deep mycoses: epidemiology and global distribution. WHO Technical Report Series. Geneva: WHO; 2018.
[4] Bonifaz A, Carrasco-Gerard E, Saúl A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001;44(1–2):1–7.
[5] Rippon JW. Chromoblastomycosis and related dermal infections. In: Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes. 3rd ed. Philadelphia: WB Saunders; 1988. p. 276–296.
[6] Queiroz-Telles F. Chromoblastomycosis: a neglected tropical disease. Rev Inst Med Trop Sao Paulo. 2015;57(Suppl 19):46–50.
[7] Hay RJ, Ashbee HR. Fungal infections. In: Rook’s Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. p. 36.1–36.90.
[8] Gupta AK, Ryder JE, Johnson AM. Cumulative itraconazole therapy for chromoblastomycosis. Int J Dermatol. 2001;40(7):453–457.
[9] McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol. 1983;8(1):1–16.
[10] Bonifaz A, Paredes-Solis V, Saul A. Treatment of chromoblastomycosis with itraconazole. Mycoses. 2004;47(5–6):213–217.
[11] Queiroz-Telles F, Santos DWCL. Chromoblastomycosis: current treatment and new therapeutic options. J Fungi. 2019;5(2):1–10.
[12] Santos DWCL, Vicente VA, Weiss VA, de Hoog GS, Gomes RR. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic and treatment update. Med Mycol. 2021;59(5):415–435.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications